ArticleMaterials (Basel, Switzerland)2026
Microhardness Recovery and Micromorphology of Demineralized Dentin Restored with Modified Glass Hybrid Material.
Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study evaluated how the addition of 5 wt% bioactive glass and 15 wt% short glass fibers to EQUIA Forte HT affects the microhardness, micromorphology, and elemental composition of demineralized dentin. Class I cavities in 28 human third molars were demineralized with 37% phosphoric acid and restored with: (1) Filtek Universal composite, (2) EQUIA Forte HT, (3) EQUIA Forte HT + 5wt% BAG, or (4) EQUIA Forte HT + 15wt% short glass fibers. After 4 weeks of storage in phosphate-buffered saline at 37 °C, the teeth were cut in half, obtaining two samples from each tooth (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.